Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model

被引:113
作者
Bulitta, Juergen B. [2 ]
Yang, Jenny C.
Yohonn, Liliana [3 ]
Ly, Neang S.
Brown, Silvia V.
D'Hondt, Rebecca E. [2 ]
Jusko, William J.
Forrest, Alan
Tsuji, Brian T. [1 ,4 ,5 ]
机构
[1] SUNY Buffalo, Lab Antimicrobial Pharmacodynam, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA
[2] Ordway Res Inst, Albany, NY 12208 USA
[3] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[4] Roswell Pk Canc Inst, Dept Pharm, Buffalo, NY 14260 USA
[5] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14260 USA
关键词
CATIONIC ANTIMICROBIAL PEPTIDES; GRAM-POSITIVE PATHOGENS; POLYMYXIN-B; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; INTRAVENOUS CIPROFLOXACIN; PERIPLASMIC PROTEINS; NEGATIVE BACTERIA; OUTER-MEMBRANE; CELL DENSITY;
D O I
10.1128/AAC.00881-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Colistin is increasingly being utilized against Gram-negative pathogens, including Pseudomonas aeruginosa, resistant to all other antibiotics. Since limited data exist regarding killing by colistin at different initial inocula (CFUo), we evaluated killing of Pseudomonas aeruginosa by colistin at several CFUo and developed a mechanism-based mathematical model accommodating a range of CFUo. In vitro time-kill experiments were performed using >= 8 concentrations up to 64 x the MIC of colistin against P. aeruginosa PAO1 and two clinical P. aeruginosa isolates at CFUo of 10(6), 10(8), and 10(9) CFU/ml. Serial samples up to 24 h were simultaneously modeled in the NONMEM VI (results shown) and S-ADAPT software programs. The mathematical model was prospectively "validated" by additional time-kill studies assessing the effect of Ca2+ and Mg2+ on killing of PAO1 by colistin. Against PAO1, killing of the susceptible population was 23-fold slower at the 10(9) CFUo and 6-fold slower at the 108 CFUo than at the 10(6) CFUo. The model comprised three populations with different second-order killing rate constants (5.72, 0.369, and 0.00210 liters/h/mg). Bacteria were assumed to release signal molecules stimulating a phenotypic change that inhibits killing. The proposed mechanism-based model had a good predictive performance, could describe killing by colistin for all three studied strains and for two literature studies, and performed well in a prospective validation with various concentrations of Ca2+ and Mg2+. The extent and rate of killing of P. aeruginosa by colistin were markedly decreased at high CFUo compared to those at low CFUo. This was well described by a mechanism-based mathematical model, which should be further validated using dynamic in vitro models.
引用
收藏
页码:2051 / 2062
页数:12
相关论文
共 74 条
  • [1] SUSCEPTIBILITY OF RECENT ISOLATES OF PSEUDOMONAS-AERUGINOSA TO GENTAMICIN, POLYMYXIN, AND 5 PENICILLINS, WITH OBSERVATIONS ON PYOCIN AND IMMUNOTYPES OF STRAINS
    ADLER, JL
    FINLAND, M
    [J]. APPLIED MICROBIOLOGY, 1971, 22 (05) : 870 - +
  • [2] Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
    Ambrose, Paul G.
    Bhavnani, Sujata M.
    Rubino, Christopher M.
    Louie, Arnold
    Gumbo, Tawanda
    Forrest, Alan
    Drusano, George L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) : 79 - 86
  • [3] Animal model pharmacokinetics and pharmacodynamics: a critical review
    Andes, D
    Craig, WA
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (04) : 261 - 268
  • [4] Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
    Aoki, Nobumasa
    Tateda, Kazuhiro
    Kikuchi, Yoshiaki
    Kimura, Soichiro
    Miyazaki, Choichiroh
    Ishii, Yoshikazu
    Tanabe, Yoshinari
    Gejyo, Fumitake
    Yamaguchi, Keizo
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) : 534 - 542
  • [5] Bauer RJ, 2008, S ADAPT MCPEM USERS
  • [6] Ways to fit a PK model with some data below the quantification limit
    Beal, SL
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2001, 28 (05) : 481 - 504
  • [7] Beal SL., 2006, NONMEM users guides
  • [8] Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
    Bergen, Phillip J.
    Li, Jian
    Nation, Roger L.
    Turnidge, John D.
    Coulthard, Kingsley
    Milne, Robert W.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 636 - 642
  • [9] BROOK I, 1989, REV INFECT DIS, V11, P361
  • [10] BULITTA JB, 2007, AAPS ANN M SAN DIEG